December 18th, 2020

Top Stories from the Microsoft DevOps Community – 2020.12.18

Zachary Deptawa
Cloud Advocate

Happy Friday everyone! My name is Zachary Deptawa, I’m a Cloud Advocate at Microsoft, and I’ll be helping to share some awesome stories and posts from our community on this blog.

Our community has been hard at work this month with some great content. The topics this week cover Azure DevOps build agents, caching in Pipelines, and more! Check them out!

Hosting an Azure DevOps build agent on Windows using Amazon EC2
Stephan walks us through how we can leverage an AWS EC2 Windows instance as a build agent for Azure DevOps. This is extremely powerful when managing a multi-cloud portfolio!

Using PowerShell Tasks and Parameters in Azure DevOps Pipelines
Nicolas explains how we can use PowerShell tasks and parameters in an Azure DevOps Pipeline by passing them as pipeline variables and arguments in an Azure DevOps PowerShell script task.

Reduce Your Build Time Using Caching in Azure Pipelines
Ivan explains how we can reduce our build times in Azure DevOps Pipelines through use of caching.

Automate Project Documentation from Azure DevOps to SharePoint on Microsoft 365
Rick explains how we can use an Azure DevOps Pipeline with simple PowerShell scripts to securely transfer documents between Microsoft 365 and SharePoint.

If you’ve written an article about Azure DevOps or find some great content about DevOps on Azure, please share it with the #AzureDevOps hashtag on Twitter!

Author

Zachary Deptawa
Cloud Advocate

Zachary is a Cloud Advocate at Microsoft with a focus on Linux (yes, really). Before that, he's played roles from monitoring technician to system administrator and professional services consultant to solutions architect at startups (Sprout Social, ClearDATA) and larger orgs (Rackspace, Amazon Web Services). These days, he advocates for awesome developer and operations experiences through talks, docs, and code. In his spare time, you can find him gigging with his bands, hanging out with his ...

More about author

0 comments

Discussion are closed.